Es gab 29 kürzliche Insider-Transaktionen für Aardvark Therapeutics, Inc. Common Stock (AARD), darunter 22 Käufe und 6 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $14.18M und die gesamten Insider-Verkäufe auf $4.73M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Lee Tien-li, Sun Nelson, Jaiman Manasi. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AARD
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-09 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
RSU-Rückgabe |
203,851 |
$13.48 |
$2.75M |
203,851 |
| 2026-02-09 |
Sun Nelson |
Chief Financial Officer |
RSU-Rückgabe |
70,549 |
$13.48 |
$951K |
70,549 |
| 2026-02-09 |
Jaiman Manasi |
Chief Medical Officer |
RSU-Rückgabe |
70,549 |
$13.48 |
$951K |
70,549 |
| 2025-12-11 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
7,000 |
$14.49 |
$101.4K |
1,551,613 |
| 2025-12-11 |
Sun Nelson |
Chief Financial Officer |
Informierter Kauf |
3,000 |
$14.40 |
$43.2K |
108,484 |
| 2025-10-15 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Optionsausübung (Verkauf) |
1,229 |
$4.24 |
$5.21K |
40,566 |
| 2025-10-15 |
Jones Bryan |
Chief Operating Officer |
Optionsausübung |
1,250 |
$4.24 |
$5.3K |
1,250 |
| 2025-09-15 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
6,500 |
$9.51 |
$61.82K |
1,539,884 |
| 2025-09-12 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
5,000 |
$8.50 |
$42.52K |
1,533,384 |
| 2025-09-11 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
6,000 |
$7.82 |
$46.93K |
1,528,384 |
| 2025-09-10 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
9,000 |
$7.91 |
$71.21K |
1,522,384 |
| 2025-09-09 |
Sun Nelson |
Chief Financial Officer |
Informierter Kauf |
6,000 |
$8.07 |
$48.44K |
105,484 |
| 2025-08-28 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
Optionsausübung (Verkauf) |
17,209 |
$4.24 |
$72.97K |
41,795 |
| 2025-06-11 |
Graf Susan E |
Director |
RSU-Zuteilung |
30,508 |
$11.29 |
$344.44K |
30,508 |
| 2025-06-11 |
Baynes Roy D. |
Director |
RSU-Zuteilung |
30,508 |
$11.29 |
$344.44K |
30,508 |
| 2025-06-11 |
Chi Jeffrey |
Director |
RSU-Zuteilung |
61,017 |
$11.29 |
$688.88K |
61,017 |
| 2025-06-11 |
Lee Tien-li |
10 Percent Owner, Officer: Chief Executive Officer |
RSU-Zuteilung |
549,534 |
$11.29 |
$6.2M |
549,534 |
| 2025-06-11 |
Tong Victor Edward Jr |
Director |
RSU-Zuteilung |
61,017 |
$11.29 |
$688.88K |
61,017 |
| 2025-06-11 |
Sun Nelson |
Chief Financial Officer |
RSU-Zuteilung |
209,826 |
$11.29 |
$2.37M |
209,826 |
| 2025-06-11 |
Jones Bryan |
Chief Operating Officer |
RSU-Zuteilung |
122,033 |
$11.29 |
$1.38M |
122,033 |
| 2025-06-11 |
Jaiman Manasi |
Chief Medical Officer |
RSU-Zuteilung |
126,999 |
$11.29 |
$1.43M |
126,999 |
| 2007-08-17 |
Creamer James W Iii |
CFO & Treasurer |
Informierter Kauf |
500 |
$1.90 |
$950.00 |
50,800 |
| 2007-03-06 |
Zimlich Joseph C |
Director |
RSU-Zuteilung |
5,000 |
$2.75 |
$13.75K |
5,000 |
| 2006-12-06 |
Zimlich Joseph C |
Director |
Informierter Kauf |
56,550 |
$1.30 |
$73.52K |
56,550 |
| 2006-11-08 |
Creamer James W Iii |
CFO & Treasurer |
Informierter Kauf |
100,000 |
$1.65 |
$165K |
100,000 |
| 2006-10-26 |
Zimlich Joseph C |
Director |
Veräußerung |
68,000 |
- |
- |
- |
| 2006-10-26 |
Zimlich Joseph C |
Director |
Informierter Kauf |
17,000 |
$3.00 |
$51K |
17,000 |
| 2006-05-12 |
Creamer James W Iii |
Chief Financial Officer |
Informierter Kauf |
300 |
$3.05 |
$915.00 |
300 |
| 2006-05-03 |
Creamer James W Iii |
Officer |
Unbekannt |
- |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
